ARCHIVES

Senate Passes Biomedical Research Extension; Could Go to President before Congress Recesses

This article is from The Cancer Letter archive.

Vol. 11 No. 30 | July 26, 1985

Download PDF Visit The Full Archive

Related Articles

Olaparib, A PARP Inhibitor, Can Reduce Tumor Size In Advanced Ovarian Cancer

August 27, 2010

NCAB, Hammer Agree On how 41 Billion To Be Handled: No String Attached

October 14, 1988

“Withheld” News Release On QRA Policies Released

November 11, 1983

In Brief: Salmon, Fidler Head ASCO, AACR; Durant, Pardee Presidents Elect; Namovicz, Other AOs Promoted

May 25, 1984

Zevalin Regimen Effective In Mantle Cell Lymphoma

January 30, 2004

In Brief: Congress Asked To Investigate Dieldrin Danger; Harvard’s Rosenberg To Be NCI Surgery Chief

April 5, 1974